EGFR mutation, smoking, and gender in advanced lung adenocarcinoma

Chien Hua Tseng, Chun Ju Chiang, Jeng Sen Tseng, Tsung Ying Yang, Kuo Hsuan Hsu, Kun Chieh Chen, Chih Liang Wang, Chih Yi Chen, Sang Hue Yen, Chun Ming Tsai, Ming Shyan Huang, Chao Chi Ho, Chong Jen Yu, Ying Huang Tsai, Jin Shing Chen, Teh Ying Chou, Ming Hsun Tsai, Hsuan Yu Chen, Kang Yi Su, Jeremy J.W. ChenHuei Wen Chen, Sung Liang Yu, Tsang Wu Liu, Gee Chen Chang

研究成果: 雜誌貢獻文章同行評審

53 引文 斯高帕斯(Scopus)


Purpose: In the current targeted therapy era, information on the effect of smoking in epidermal growth factor receptor (EGFR)-mutant lung cancer patients is scarce. Results: In total, 11,678 adenocarcinoma patients were enrolled. Of these, 33.3% and 91.8% of male and female patients were non-smokers, respectively. An increased amount of smoking (P < 0.001 for trend), fewer smoke-free years (P < 0.001 for trend), and younger age of smoking initiation (P = 0.034 for trend) were all associated with significantly lower EGFR mutation rates. Smokers had a shorter median overall survival (OS) among both EGFR-mutant and EGFR-wild type patients (17.8 vs. 21.1 months, and 7.9 vs. 11.4 months respectively; both P < 0.001). Among patients with EGFR-mutant adenocarcinoma, younger smokers were associated with shorter OS (P = 0.047). In multivariate analysis, female gender was an independent prognostic factor for OS (hazard ratio: 0.86 [95% confidence interval (CI): 0.80-0.93]; P < 0.001 in the EGFRmutant group and 0.88 [95% CI: 0.81-0.96]; P = 0.004 in the EGFR-wild type group). Materials and Methods: We reviewed the National Lung Cancer database (Taiwan) to assess the impact of smoking on the EGFR mutation rate and survival in advanced lung adenocarcinoma patients during 2011 and 2014 retrospectively. Conclusions: Smoking was associated with lower incidence of EGFR mutation rate and reduced OS of advanced lung adenocarcinoma patients in a dose-dependent manner. In addition to EGFR mutation and smoking, gender also plays an important role in survival among these patients.

頁(從 - 到)98384-98393
出版狀態已發佈 - 1月 1 2017

ASJC Scopus subject areas

  • 腫瘤科


深入研究「EGFR mutation, smoking, and gender in advanced lung adenocarcinoma」主題。共同形成了獨特的指紋。